CX Engineeringsp. z o.o.

Manufacture of medical and dental instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-06-14
Share capital
4 914 500,00 PLN
Registered address
ul. Przemysłowa 17, 32-083 Balice, Poland
Electronic delivery address
AE:PL-13420-40163-BCBTR-19

Financials

The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 12.03mMedianUSD 244.19kAverageUSD 73.97m
Net profit
This companyUSD 318.44kMedianUSD 8.66kAverageUSD 3.21m
Operating costs
This companyUSD 11.67mMedianUSD 263.70kAverageUSD 67.37m
Assets
This companyUSD 6.45mMedianUSD 231.06kAverageUSD 47.07m

Bank accounts

Registered as a VAT taxpayer on 2019-06-21. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

10 public aid cases recorded, with a total value of $3,452,781.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$459
De minimis aid (in accordance with Commission Regulation 2023/2831)
$9,945
Regional investment aid
$3.3M

European Funds

ProjectEU co-financing
Wdrożenie wyników prac B+R – celem uruchomienia pełnoskalowej produkcji zaawansowanych i innowacyjnych w skali świata rozwiązań produktowych dedykowanych branży okulistycznej
$3.1M

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Piotr Andrzej Barański — President of the Management Board
Anna Piotrowska — Vice President of the Management Board
Bożena Wawrzyńczyk — Attorney-in-fact (joint)

Manner of representation

The following persons are authorized to submit declarations of will on behalf of the company and to perform all judicial and extrajudicial acts of the company: in the case of a one-person management board, the President of the Management Board independently; in the case of a multi-member management board, the President of the Management Board independently, or a member of the management board acting jointly with a commercial proxy (provided that a commercial proxy is appointed in the company).

Ownership

OwnerSharesShare valueStake
Piotr Andrzej Barański (40)
4,920$132,901.1310.0112%
44,225$1,194,624.5389.9888%

Beneficial owners

Person
Leszek Piątek (68)
Krzysztof Zdzisław Smolarski (70)

Subsidiaries

NameStake
Strabiscansp. z o.o.
91.9%

Competitors

Name
InmedS.A.
Verdentsp. z o.o.
Metrum Cryoflexsp. z o.o.
Poldentsp. z o.o.
Corning HtlS.A.
Lubelskie Zakłady Farmaceutyczne PolfaS.A.
MargomedS.A.
YAVOsp. z o.o.
Complevita Dygut & Piwowarsp. z o.o.
Optyk Kołdersp. j.

Change history

DateEvent
2023-06-05Share capital change
2022-03-10Share capital change
2019-11-19Share capital change
2019-08-30Name change
2019-06-14Entered in the register

FAQ

Last updated: 2026-04-13